logo Web 2.0 Resource for the FDA

LATISSE

Drug Names(s) LATISSE - website »
FDA Application No (NDA) 022369
Active Ingredient(s) BIMATOPROST
Company ALLERGAN
Chemical Type 6 New indication
Review Classification P Priority review drug
Products on Application (NDA) 022369
Drugname Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code
LATISSE BIMATOPROST 0.03% SOLUTION/DROPS; TOPICAL Prescription Yes
Approval History
Action Date Supplement Number Action Documents Note
2008-12-24 000 Approval -
powered by Zymergi